Jeffrey Friedland
Chief Executive Officer at Friedland Global Capital Pte. Ltd.
Profile
Jeffrey Friedland is the founder of Israel Plant Sciences Ltd.
(founded in 2015).
He is currently the Chief Executive Officer of Friedland Global Capital Pte.
Ltd.
(since 1979), the Chief Executive Officer of Global Corporate Strategies LLC (since 2011), and a Director at Cannrx Technology, Inc. (current position).
He has previously served as the Chief Executive Officer & Director of Kinder Holding Corp.
and Nexien BioPharma, Inc. He was also a Director at China GengSheng Minerals, Inc. from 2013 to 2014.
Additionally, he has worked as the Managing Director of Friedland Capital Equity Research LLC.
Mr. Friedland obtained his undergraduate degree from The University of Colorado.
Jeffrey Friedland active positions
| Companies | Position | Start |
|---|---|---|
| Friedland Global Capital Pte. Ltd. | Chief Executive Officer | - |
| Global Corporate Strategies LLC | Chief Executive Officer | 2010-12-31 |
Cannrx Technology, Inc.
 Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Director/Board Member | - |
Former positions of Jeffrey Friedland
| Companies | Position | End |
|---|---|---|
| NEXIEN BIOPHARMA, INC. | Chief Executive Officer | 2018-03-06 |
| CHINA GENGSHENG MINERALS, INC. | Director/Board Member | 2014-05-11 |
Israel Plant Sciences Ltd.
 Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Founder | - |
Kinder Holding Corp.
 Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Chief Executive Officer | - |
| Friedland Capital Equity Research LLC | President | - |
Training of Jeffrey Friedland
| The University of Colorado | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CHINA GENGSHENG MINERALS, INC. | Non-Energy Minerals |
| NEXIEN BIOPHARMA, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Kinder Holding Corp.
Kinder Holding Corp. Financial ConglomeratesFinance Kinder Holding Corp. engages in the research and development of cannabis cannabinoid-based drugs for various medical conditions and disorders. It focuses on identifying the appropriate compounds for its myotonic and muscular diseases drug candidate. The company was founded on November 10, 1952 and is headquartered in San Marino, CA. | Finance |
| Friedland Capital Equity Research LLC | Finance |
| Friedland Global Capital Pte. Ltd. | |
| Global Corporate Strategies LLC | |
Israel Plant Sciences Ltd.
Israel Plant Sciences Ltd. Agricultural Commodities/MillingProcess Industries Israel Plant Sciences Ltd. is a holding Israeli company with subsidiaries that specialize in cannabis breeding, plant breeding support software development, and medicinal extraction from cannabis. The company is based in Herzliya, Israel. and has subsidiaries in Canada. The company was founded in 2015 by Jeffrey Friedland and Oded Sagee. | Process Industries |
Cannrx Technology, Inc.
Cannrx Technology, Inc. Medical SpecialtiesHealth Technology CannRx Technology, Inc. is a private company that specializes in developing scientifically-based proprietary cannabis technologies. CannRx Technology, Inc. is based in New York, NY. The company's focus is on creating transformative technology that delivers more effective, higher bioavailability, scientifically formulated cannabis products. The company has developed patented, breakthrough technologies that will transform the cannabis industry. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Friedland
